NeoGenomics, Inc. - Common Stock (NQ:NEO)

17.25 +0.37 (+2.19%)

Delayed Quote Updated: 4:00 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO

June 15, 2025

From Pomerantz LLP

Via GlobeNewswire

3 Unprofitable Stocks in Hot Water

June 11, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

3 Volatile Stocks in Hot Water

May 30, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

May 28, 2025

From NeoGenomics, Inc.

Via Business Wire

A Look at NeoGenomics's Upcoming Earnings Report ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For April 29, 2025 ↗

April 29, 2025

Via Benzinga

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

May 22, 2025

From NeoGenomics, Inc.

Via Business Wire

Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know

May 21, 2025

A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could...

Via StockStory

Topics Bonds Stocks

NeoGenomics to Participate in Upcoming June Investor Conferences

May 20, 2025

From NeoGenomics, Inc.

Via Business Wire

Insights Ahead: NeoGenomics's Quarterly Earnings ↗

April 28, 2025

Via Benzinga

3 Healthcare Stocks with Mounting Challenges

May 20, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

3 Russell 2000 Stocks in the Doghouse

May 15, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

NEO Q1 Earnings Call: Sales Growth, Pharma Headwinds, and Pathline Integration Shape Outlook

May 13, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $168 million. On the other hand, the...

Via StockStory

Earnings Scheduled For May 9, 2025 ↗

May 09, 2025

Via Benzinga

Assessing NeoGenomics: Insights From 9 Financial Analysts ↗

May 06, 2025

Via Benzinga

It's Not Too Late to Jump on These Under-the-Radar Momentum Plays

May 06, 2025

These three stocks may fly under the radar, but their recent price increases could appeal to investors seeking a momentum play.

Via MarketBeat

Topics World Trade

3 Small-Cap Stocks Walking a Fine Line

May 05, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

NeoGenomics Pays Off 1.25% Convertible Senior Notes

May 01, 2025

From NeoGenomics, Inc.

Via Business Wire

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

April 30, 2025

Via Benzinga

Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

April 30, 2025

Via Benzinga

Tuesday's session: top gainers and losers ↗

April 29, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Why NeoGenomics (NEO) Stock Is Nosediving

April 29, 2025

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the company reported disappointing first-quarter 2025 earnings as sales fell below...

Via StockStory

Topics Artificial Intelligence

Keep an eye on the top gainers and losers in Tuesday's session. ↗

April 29, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 29, 2025

Via Benzinga

These stocks are gapping in today's session ↗

April 29, 2025

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings ↗

April 29, 2025

Via Benzinga

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

April 29, 2025

Via StockStory

NeoGenomics Reports First Quarter 2025 Results

April 29, 2025

From NeoGenomics, Inc.

Via Business Wire

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

April 28, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings tomorrow morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

April 22, 2025

From NeoGenomics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.